GE Healthcare looks to self-manufacture imaging agent Optison

01/16/2013 | Pharmaceutical Business Review Online

GE Healthcare is seeking approval to independently manufacture Optison, a contrast agent for cardiac imaging. The company has submitted a supplemental new drug application for the agent to U.S. regulators. "While we cannot predict a timeline for regulatory authority approval, we look forward to servicing the U.S. cardiology community directly in 2013," said GE Healthcare's Stephen Lightfoot.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ